Altech Chemicals Ltd (ASX:ATC) is pleased to report that following a recent presentation to Euler Hermes Aktiengesellschaft ("Hermes") in Hamburg, Germany and its preliminary evaluation of the Company's proposed high purity alumina project, Hermes has issued a Letter of Interest confirming in principle support under the export credit insurance guarantee scheme of the Federal Republic of Germany.
Altech Chemicals Limited (Altech/the Company) (ASX:ATC) advises that exploration licence E70/4718 (Kerrigan project) has been granted. The licence covers an area of approximately 480km2, is on freehold agricultural land and contains Inferred Kaolin Mineral Resources of 85 million tonnes at 85.1% brightness.
Altech Chemicals (ASX:ATC) is pleased to advise that it has executed an exclusive mandate with German KfW IPEX-Bank GmbH, to provide advisory and structuring services in relation to the provision of senior debt project financing for the Company's proposed high purity alumina project.
Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, announced today the commencement of a trial of its cancer vaccine technology, Kvax, in combination with chemotherapy as a treatment for canine lymphoma.
Altech Chemicals Limited (ASX:ATC) is pleased to provide an update on the detailed design work that is currently underway for its proposed high purity alumina (HPA) project.
Altech Chemicals Limited (ASX:ATC) is pleased to provide an update on the progress of financing activities for its proposed high purity alumina project (HPA Project).
Altech Chemicals Limited (Altech/the Company) (ASX:ATC) presents the quarterly activity report for the three months ended 30 September 2015.
